Both in Biotechnology
PharmaCyte Biotech vs IN8bio
Over the past year PMCB returned −57.6% and INAB returned −49.1%; their daily moves had a correlation of 0.05.
PMCB −57.6% INAB −49.1%Growth of $1, one year, split-adjusted
| Metric | PMCB | INAB |
|---|---|---|
| Price | $0.3752 | $0.8300 |
| Market cap | $4.0M | $8.2M |
| Today | −1.52% | −10.82% |
| 1 month | −7.5% | −40.7% |
| 6 months | −53.1% | −48.1% |
| Year to date | −48.2% | −64.5% |
| 1 year | −57.8% | −49.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $30.5M | $17.8M |
| Dividend yield | — | — |
| Volatility (60d) | 70.4% | 85.7% |
| Short % of float | 0.8% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).